Swissmedic Approves First Malaria Treatment for Newborns, Paving Way for African Rollout
🩺 Geneva, July 8, 2025 — In a landmark decision, Switzerland’s drug regulator Swissmedic has approved Coartem Baby, the world’s first malaria treatment specifically formulated for newborns and infants weighing less than five kilograms. The approval addresses a critical gap in malaria care for the youngest and most vulnerable patients in regions where the disease […]
Continue Reading